GlassScriptPhysician profile
Fassil B Mesfin
NPI 1992968218
$14,676.48
in general payments reported to CMS, 2019-2025
17 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,363 · 2020: $1,642 · 2021: $1,788 · 2022: $3,746 · 2023: $492 · 2024: $274 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.93 |
| Travel and Lodging | $203.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $4,628.07 | 2019-2020 | |
| Globus Medical, INC. | $4,384.77 | 2021-2023 | Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $1,763.27 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,356.91 | 2019 | |
| Medtronic, INC. | $774.42 | 2022-2025 | Osteocool Rf Ablation System, Stealthstation S8 Platform, Kyphon Express II Kyphopak Tray |
| Gs Solutions, INC. | $333.85 | 2019-2022 | |
| Ulrich Medical USA, INC. | $325.19 | 2020-2022 | |
| Synthes Gmbh | $250.00 | 2021 | |
| Depuy Synthes Sales INC. | $198.60 | 2019-2024 | Symphony |
| Nuvasive, INC. | $165.29 | 2022 | |
| Baxter Healthcare | $140.81 | 2025 | Floseal |
| Spinal Elements, INC. | $115.83 | 2021 | |
| Irras USA, INC. | $105.91 | 2023 | |
| Nanohive Medical LLC | $95.94 | 2021 | |
| Boston Scientific Corporation | $37.62 | 2021-2024 | Na |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fassil Mesfin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.